Quantification of BSA-loaded chitosan/oligonucleotide nanoparticles using reverse-phase high-performance liquid chromatography

© 2018, Springer-Verlag GmbH Germany, part of Springer Nature. Therapeutic proteins are administered subcutaneously because of their instability in the gastrointestinal tract. Current research suggests that polymeric-based nanoparticles, microparticles and liposomes are ideal nanocarriers to encapsu...

Full description

Bibliographic Details
Main Authors: Wong, Chun Yuen, Martinez, Jorge, Al-Salami, Hani, Dass, Crispin
Format: Journal Article
Published: Springer 2018
Online Access:http://hdl.handle.net/20.500.11937/71363
_version_ 1848762460128935936
author Wong, Chun Yuen
Martinez, Jorge
Al-Salami, Hani
Dass, Crispin
author_facet Wong, Chun Yuen
Martinez, Jorge
Al-Salami, Hani
Dass, Crispin
author_sort Wong, Chun Yuen
building Curtin Institutional Repository
collection Online Access
description © 2018, Springer-Verlag GmbH Germany, part of Springer Nature. Therapeutic proteins are administered subcutaneously because of their instability in the gastrointestinal tract. Current research suggests that polymeric-based nanoparticles, microparticles and liposomes are ideal nanocarriers to encapsulate proteins for disease management. In order to develop a successful drug delivery system, it is crucial to determine drug release profile and stability. However, the non-active excipients in polymeric formulations can influence the quantification of proteins in analytical techniques. This study investigated the effect of nine common polymers on quantification of bovine serum albumin (BSA) using RP-HPLC method. The technique offers advantages such as short analytical time, high accuracy and selectivity. In the meantime, the technique can be employed to separate proteins including BSA, insulin and pigment epithelium-derived factor (PEDF). Furthermore, the RP-HPLC method was applied to quantify the drug release pattern of a novel BSA-loaded nanoparticulate formulation in simulated gastric and intestinal fluids. The nanoparticles were formulated by natural polymer (chitosan) and oligonucleotide (Dz13Scr) using complex coacervation. The prepared particles were found to have small size (337.87 nm), low polydispersity index (0.338) and be positively charged (10.23 mV). The in vitro drug release patterns were characterised using the validated RP-HPLC method over 12 h. [Figure not available: see fulltext.].
first_indexed 2025-11-14T10:47:55Z
format Journal Article
id curtin-20.500.11937-71363
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T10:47:55Z
publishDate 2018
publisher Springer
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-713632018-12-13T09:33:29Z Quantification of BSA-loaded chitosan/oligonucleotide nanoparticles using reverse-phase high-performance liquid chromatography Wong, Chun Yuen Martinez, Jorge Al-Salami, Hani Dass, Crispin © 2018, Springer-Verlag GmbH Germany, part of Springer Nature. Therapeutic proteins are administered subcutaneously because of their instability in the gastrointestinal tract. Current research suggests that polymeric-based nanoparticles, microparticles and liposomes are ideal nanocarriers to encapsulate proteins for disease management. In order to develop a successful drug delivery system, it is crucial to determine drug release profile and stability. However, the non-active excipients in polymeric formulations can influence the quantification of proteins in analytical techniques. This study investigated the effect of nine common polymers on quantification of bovine serum albumin (BSA) using RP-HPLC method. The technique offers advantages such as short analytical time, high accuracy and selectivity. In the meantime, the technique can be employed to separate proteins including BSA, insulin and pigment epithelium-derived factor (PEDF). Furthermore, the RP-HPLC method was applied to quantify the drug release pattern of a novel BSA-loaded nanoparticulate formulation in simulated gastric and intestinal fluids. The nanoparticles were formulated by natural polymer (chitosan) and oligonucleotide (Dz13Scr) using complex coacervation. The prepared particles were found to have small size (337.87 nm), low polydispersity index (0.338) and be positively charged (10.23 mV). The in vitro drug release patterns were characterised using the validated RP-HPLC method over 12 h. [Figure not available: see fulltext.]. 2018 Journal Article http://hdl.handle.net/20.500.11937/71363 10.1007/s00216-018-1319-9 Springer restricted
spellingShingle Wong, Chun Yuen
Martinez, Jorge
Al-Salami, Hani
Dass, Crispin
Quantification of BSA-loaded chitosan/oligonucleotide nanoparticles using reverse-phase high-performance liquid chromatography
title Quantification of BSA-loaded chitosan/oligonucleotide nanoparticles using reverse-phase high-performance liquid chromatography
title_full Quantification of BSA-loaded chitosan/oligonucleotide nanoparticles using reverse-phase high-performance liquid chromatography
title_fullStr Quantification of BSA-loaded chitosan/oligonucleotide nanoparticles using reverse-phase high-performance liquid chromatography
title_full_unstemmed Quantification of BSA-loaded chitosan/oligonucleotide nanoparticles using reverse-phase high-performance liquid chromatography
title_short Quantification of BSA-loaded chitosan/oligonucleotide nanoparticles using reverse-phase high-performance liquid chromatography
title_sort quantification of bsa-loaded chitosan/oligonucleotide nanoparticles using reverse-phase high-performance liquid chromatography
url http://hdl.handle.net/20.500.11937/71363